Skip to main content
(352) 265-0725

Karen Daily, DO : Research

Cancer Specialist (Oncologist), Hematology and Oncology Specialist

Photo of Karen Daily
(352) 265-0725 MyUFHealth

Research at a glance

Top areas of exploration

  • Breast Neoplasms , 10 publications
  • Neoplasm Recurrence, Local , 3 publications
  • Antineoplastic Combined Chemotherapy Protocols , 3 publications
  • Antineoplastic Agents, Hormonal , 3 publications

Research activity

43 publications

552 citations

Why is this important?

Active clinical trials

E-Mindfulness Approaches for Living After Breast Cancer (HEAL-ABC)

NRG-CC015 is a prospective, randomized phase III clinical trial to evaluate the efficacy of two distinct digital approaches for delivering a mindfulness-based intervention: a live, instructor-led version delivered over Zoom (MAPs LO), and an…

Investigator
Karen Daily
Status
Accepting Candidates
Ages
18 Years - 50 Years
Sexes
All

My publications

43 publications

2025

Letter: The Role of a Division Education Director in Advancing Palliative Care Education.

Journal of palliative medicine

PubMed • Publisher's site

2025

Erratum: Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient Neoplasms.

JCO precision oncology

PubMed • Publisher's site

2025

Impact of Pre-Existing Frailty on Cardiotoxicity Among Breast Cancer Patients Receiving Adjuvant Therapy.

JACC. CardioOncology

PubMed • Publisher's site

2024

Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient Neoplasms

JCO Precision Oncology

Publisher's site